SUPPREMOL GMBH

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUPPREMOL GMBH.The latest application filed is for "highly concentrated formulations of soluble fc receptors".

Company Profile

12.17.12

SUPPREMOL GMBH - Martinsried DE
SUPPREMOL GMBH - Martinsried/Munich DE
SUPPREMOL GMBH - Martinsreid/Munich DE
SUPPREMOL GMBH - Munich N/A DE
SuppreMol GmbH - Martinsried/Munchen N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS App 20220296668 - Sondermann; Peter ; et al.	2022-09-22
Highly concentrated formulations of soluble Fc receptors Grant 11,266,708 - Sondermann , et al. March 8, 2	2022-03-08
In vitro method for determining the stability of compositions comprising soluble Fc gamma receptor(s) Grant 10,866,247 - Sondermann , et al. December 15, 2	2020-12-15
Antibodies directed to Fc gamma receptor IIB and Fc epsilon receptor Grant 10,730,946 - Carle , et al.	2020-08-04
Vector encoding an Fc gamma receptor IIB protein and composition of the encoded protein Grant 10,669,324 - Sondermann , et al.	2020-06-02
Anti-Fc-gamma receptor IIB antibodies and uses thereof Grant 10,407,499 - Sondermann , et al. Sept	2019-09-10
HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS App 20190231842 - Sondermann; Peter ; et al.	2019-08-01
Highly concentrated formulations of soluble Fc receptors Grant 10,226,504 - Sondermann , et al.	2019-03-12
Method for treating an inflammatory disease and/or an autoimmune disease with a soluble Fc.gamma.RIIb Grant 10,028,998 - Buckel , et al. July 24, 2	2018-07-24
Soluble Fc.gamma. receptor for treatment of autoimmune bullous diseases Grant 9,981,009 - Ludwig , et al. May 29, 2	2018-05-29
Novel Antibodies Directed To Fc Gamma Receptor Iib And Fc Epsilon Receptor App 20170226208 - Carle; Anna ; et al.	2017-08-10
Soluble Fc Gamma Receptor For Treatment Of Autoimmune Bullous Diseases App 20160235814 - Ludwig; Ralf ; et al.	2016-08-18
In vitro method for determining the stability of compositions comprising soluble Fc gamma receptor(s) App 20160195541 - Sondermann; Peter ; et al.	2016-07-07
Novel Anti-fc-gamma Receptor Iib Antibodies And Uses Thereof App 20160185857 - Sondermann; Peter ; et al.	2016-06-30
HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS App 20160095895 - Sondermann; Peter ; et al.	2016-04-07
Fc Gamma Receptor Iib Variants App 20150274804 - Sondermann; Peter ; et al.	2015-10-01
Multimeric Fc receptor polypeptides Grant 8,729,247 - Hogarth , et al. May 20, 2	2014-05-20
Method for Treating or Preventing an Inflammatory Disease and/or an Autoimmune Disease App 20140120080 - Buckel; Peter ; et al.	2014-05-01
MULTIMERIC Fc RECEPTOR POLYPEPTIDES App 20130089893 - Hogarth; Phillip Mark ; et al.	2013-04-11
Multimeric Fc receptor polypeptides Grant 8,354,109 - Hogarth , et al. January 15, 2	2013-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.